101 related articles for article (PubMed ID: 20676911)
1. Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats.
Hayashi T; Abe F; Kato M; Saito H; Ueyama J; Kondo Y; Imai K; Katoh M; Nadai M; Hasegawa T
J Infect Chemother; 2011 Feb; 17(1):24-9. PubMed ID: 20676911
[TBL] [Abstract][Full Text] [Related]
2. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
[TBL] [Abstract][Full Text] [Related]
3. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
4. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
Sugie M; Asakura E; Zhao YL; Torita S; Nadai M; Baba K; Kitaichi K; Takagi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2004 Mar; 48(3):809-14. PubMed ID: 14982769
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats.
Mano Y; Usui T; Kamimura H
Eur J Drug Metab Pharmacokinet; 2006; 31(2):117-21. PubMed ID: 16898080
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
8. Key determinants of the circulatory exposure of organic anions: differences in hepatic uptake between multidrug resistance-associated protein 2 (Mrp2)-deficient rats and wild-type rats.
Kosaka K; Watanabe T; Susukida T; Aoki S; Sekine S; Kume T; Ito K
Xenobiotica; 2015; 45(6):556-62. PubMed ID: 25539456
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport.
Yamaguchi S; Zhao YL; Nadai M; Yoshizumi H; Cen X; Torita S; Takagi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2006 Jan; 50(1):80-7. PubMed ID: 16377671
[TBL] [Abstract][Full Text] [Related]
10. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
11. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and an interspecies scaling of pharmacokinetic parameters.
Hayakawa H; Fukushima Y; Kato H; Fukumoto H; Kadota T; Yamamoto H; Kuroiwa H; Nishigaki J; Tsuji A
Drug Metab Dispos; 2003 Nov; 31(11):1409-18. PubMed ID: 14570774
[TBL] [Abstract][Full Text] [Related]
13. Mrp2 is involved in benzylpenicillin-induced choleresis.
Ito K; Koresawa T; Nakano K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G42-9. PubMed ID: 15194559
[TBL] [Abstract][Full Text] [Related]
14. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
15. Biliary excretion of phenolphthalein sulfate in rats.
Tanaka H; Sano N; Takikawa H
Pharmacology; 2003 Aug; 68(4):177-82. PubMed ID: 12837971
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
17. Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats using loperamide, paclitaxel, sulfasalazine, and carboxydichlorofluorescein pharmacokinetics.
Zamek-Gliszczynski MJ; Bedwell DW; Bao JQ; Higgins JW
Drug Metab Dispos; 2012 Sep; 40(9):1825-33. PubMed ID: 22711747
[TBL] [Abstract][Full Text] [Related]
18. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Chen C; Scott D; Hanson E; Franco J; Berryman E; Volberg M; Liu X
Pharm Res; 2003 Jan; 20(1):31-7. PubMed ID: 12608533
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
Moriwaki T; Yasui H; Yamamoto A
Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
[TBL] [Abstract][Full Text] [Related]
20. Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.
Muraoka I; Hasegawa T; Nadai M; Wang L; Haghgoo S; Tagaya O; Nabeshima T
Antimicrob Agents Chemother; 1995 Jan; 39(1):70-4. PubMed ID: 7695332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
